 ATLANTA-- BUSINESS WIRE --Virios Therapeutics, Inc. Nasdaq: VIRI, a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia, today announced that Greg Duncan, Chairman and CEO of Virios Therapeutics will be attending and presenting at the Planet MicroCap Showcase, which is taking place virtually December 6 8, 2022. 